1
Coordinator: Howard B. Chrisman, MD, MBA VENOUS ACCESS (HANDS-ON) (WK39) Objectives: Upon completion of this workshop, the attendee should be able to: Sean M. Tutton, MD Ann Covey, MD Lynn Brody, MD Daniel Croteau, MD Kevin Dickey, MD David C. Youmans, MD Kyran Dowling, MD John A. Lippel1, MD P.c. Sherry, MD Donald F. Denny, Jr, MD Mark B. Saker, MD David Martin, PA-C Philip C. Pieters, MD Harjit Singh, MD Curtis A. Lewis, MD Gary P. Siskin, MD James M. Cooper, MD Jacqueline P. Jahnke, MD Peter N. SWischuk, MD Thomas M. Vesely, MD Michael G. Wysoki, MD zachary Rattner, MD J. Fritz Angle, MD Scott A. Resnick, MD Riad Salem, MD, MBA Jain1e Tismdo, MD, FACR, FACC 1. List the variety of commercially available ve- nous access deVices, describe their advantages and disadvantages, and review the issues in- volved in selecting an appropriate access device. 2. Review the basic techniques involved in percu- taneous cannulation of central veins utilizing venography and ultrasound guidance. 3. Review basic insertion techniques for implant- ing peripherally inserted central catheters and peripheral ports. 4. Review basic insertion techniques for implant- ing tunneled central venous catheters with par- ticular emphasis on dialysis catheters. 5. Review basic insertion techniques for implanting chest wall subclltaneous venous access devices. 6. Demonstrate basic surgical wound closure tech- nique with particular emphasis on the subcutic- ular closure. 7. Discuss how to manage common problems and complications related to venous access devices. Coordinator: Bradford Johns Wood, MD Murray Asch, MD Debra Ann Gervais, MD Ziv Neeman, MD John R. Kachura, MD Bradford Johns Wood, MD Jeet Sandhu, MD Lynn Brody, MD Peter Mueller, MD Damian E. Dupuy, MD Mark B. Saker, MD Michael C. Soulen, MD 2. Practice techniques of ultrasound guided tumor ablation in an animal tissue model. 3. Describe the changes in the ultrasound appear- ance of tissue during and folloWing RF ablation in a tissue phantom. 4. List a variety of commercially available equip- ment for percutaneous tumor ablation. 5. Practice techniques for ultrasound-guided clyoablation in an animal tissue model. NEUROINTERVENTIONS: CAROTID (HANDS-ON) (WK40) Objectives: Upon completion of this workshop, the attendee should be able to: 1. Discuss the urgency of treating critical vascular injuries and how to target examinations for rapid diagnosis and treatment. 2. Recognize the advantages/risks of transcatheter intervention in trauma. 3. Review the available embolic agents and the principles by which they are chosen for treating traumatic injuries. THE ROLE OF THE IR IN TRAUMA CARE (WK37) Objectives: Upon completion of this workshop, the attendee should be able to: IR MANAGEMENT OF PORTAL HYPERTENSION (TIPS) (WK36) Objectives: Upon completion of this workshop, the attendee should be able to: 4. Discuss how to handle unusual or complex sit- uations that may arise dUring recanalization pro- cedures. Coordinator: Mun-ay]. Mazer, MD Scott Savader, MD Charles P. Semba, MD Matthew A. Mauro, MD Murray]. Mazer, MD David W. Hunter, NID Elvird V. Lang, MD 1. Define the indications and contraindications for TIPS. 2. Explain the pre-procedure patient evaluation and patient selection for TIPS. 3. Review hepatic vascular anatomy relevant to TIPS. 4. Describe adjunctive techniques to facilitate por- tal vein puncture. 5. Outline step-by-step approach to perform a TIPS. 6. Define the procedural endpoints. 7. Provide appropriate follow-up regimens. 8. Review successful strategies for the challenging TIPS case. Coordinator: Robert K.W. Ryu, MD Michael D. Darcy, MD RObelt K. Kerlan, Jr, MD Janette D. Durham, NID John]. Borsa, MD Ziv Haskal, MD Riad Salem, MD, MBA David P. Brophy, MD Gail 1. Peters, tvID Nilesh H. Patel, MD Coordinator: Michael Katz, MD Micl1ael Katz, MD Douglas M. Coldwell, MD Eric K. Hoffer, MD Donald S. Harrell, MD Abbas A. Chamsuddin, MD John]. Borsa, MD ULTRASOUND GUIDED ABLATION (HANDS-ON) (WK38) Objectives: Upon completion of this workshop, the attendee should be able to: 1. Be familiar with the variable indications and requirements for percutaneous radiofrequency ablation (RF) of tumors. P329
